A Covid vaccine compensation scheme could be set up after thousands claimed they have been left disabled as a result of the AstraZeneca jab, The Telegraph has learnt ...
Fierce Pharma Asia—AstraZeneca's China fallout; Pfizer's $1B plan in China; Incyte-Sun JAK dispute
AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...
Pharmaceutical giant AstraZeneca said Thursday that the head of its China operations had been detained, after reports the ...
Leerink Partners analyst Andrew Berens has maintained their bullish stance on AZN stock, giving a Buy rating on November 6. Andrew ...
Pharmaceutical Technology on MSN12d
EC approves AstraZeneca’s Fasenra for EGPA treatmentThe European Commission (EC) has approved AstraZeneca ‘s Fasenra (benralizumab) as an add-on therapy for adults with ...
AstraZeneca Plc said its experimental obesity pill was well tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines. The ...
Adar Poonawalla, CEO of Serum Institute of India and Chairman of Poonawalla Fincorp, has recently acquired a 50% stake in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback